190 related articles for article (PubMed ID: 26502694)
81. From the Food and Drug Administration.
Nightingale SL
JAMA; 1998 Sep; 280(10):872. PubMed ID: 9739956
[No Abstract] [Full Text] [Related]
82. Erythema nodosum leprosum: report of two cases.
Aggarwal R; Gupta O; Beg S; Prasad R
Diagn Cytopathol; 2013 Apr; 41(4):366-8. PubMed ID: 21932352
[TBL] [Abstract][Full Text] [Related]
83. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
[TBL] [Abstract][Full Text] [Related]
84. [Persistent type 2 lepra reaction (erythema nodosum) and clofazimine-induced lethal enteropathy].
Rodríguez G; Pinto R; López F; Gómez Y
Biomedica; 2009 Mar; 29(1):18-24. PubMed ID: 19753835
[TBL] [Abstract][Full Text] [Related]
85. Preparing for thalidomide's comeback.
Vanchieri C
Ann Intern Med; 1997 Nov; 127(10):951-2. PubMed ID: 9446509
[No Abstract] [Full Text] [Related]
86. [Review: update on erythema nodosum leprosum].
Morand JJ; Badiane C; Bobin P
Med Trop (Mars); 2004; 64(5):423-30. PubMed ID: 15771008
[TBL] [Abstract][Full Text] [Related]
87. Complex Type 2 Reactions in Three Patients with Hansen's Disease from a Southern United States Clinic.
Leon KE; Salinas JL; McDonald RW; Sheth AN; Fairley JK
Am J Trop Med Hyg; 2015 Nov; 93(5):1082-6. PubMed ID: 26304919
[TBL] [Abstract][Full Text] [Related]
88. Bangkok Workshop on Leprosy Research. Treatment of reactions and nerve damage.
Naafs B
Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4 Suppl):S21-8. PubMed ID: 9030120
[No Abstract] [Full Text] [Related]
89. Cytodiagnosis of erythema nodosum leprosum. A case report.
Anshu ; Gangane N; Vagha S; Samal N
Acta Cytol; 2002; 46(2):386-8. PubMed ID: 11917590
[TBL] [Abstract][Full Text] [Related]
90. Lucio's phenomenon: A systematic literature review of definition, clinical features, histopathogenesis and management.
Frade MAC; Coltro PS; Filho FB; Horácio GS; Neto AA; da Silva VZ; Westin AT; Guimarães FR; Innocentini LMAR; Motta ACF; Farina JA
Indian J Dermatol Venereol Leprol; 2022; 88(4):464-477. PubMed ID: 34672479
[TBL] [Abstract][Full Text] [Related]
91. The schizophrenic career of a "monster drug".
Crawford CL
Pediatrics; 2003 Mar; 111(3):712. PubMed ID: 12612270
[No Abstract] [Full Text] [Related]
92. Pulsed corticosteroid therapy in patients with chronic recurrent ENL: a pilot study.
Girdhar A; Chakma JK; Girdhar BK
Indian J Lepr; 2002; 74(3):233-6. PubMed ID: 12708702
[TBL] [Abstract][Full Text] [Related]
93. [Leprosy in Guadeloupe 1980-1990: development and management in the general hospital].
Strobel M; Gros de Beler A; Arnaud JP; Sibille G
Bull Soc Pathol Exot; 1992; 85(1):22-5. PubMed ID: 1596953
[TBL] [Abstract][Full Text] [Related]
94. A real-world study of low-dose thalidomide in severe erythema nodosum leprosum highlighting its mechanistic rationale in a resource-constrained target population.
Bathula S; Sardana K; Mathachan SR; Khurana A; Ahuja A; Paliwal P
Int J Dermatol; 2023 Jan; 62(1):48-55. PubMed ID: 35924464
[TBL] [Abstract][Full Text] [Related]
95. Evaluation of the influence of genetic variants in Cereblon gene on the response to the treatment of erythema nodosum leprosum with thalidomide.
Costa PDSS; Maciel-Fiuza MF; Kowalski TW; Fraga LR; Feira MF; Camargo LMA; Caldoncelli DIO; Silveira MIDS; Schuler-Faccini L; Vianna FSL
Mem Inst Oswaldo Cruz; 2022; 117():e220039. PubMed ID: 36383784
[TBL] [Abstract][Full Text] [Related]
96. Reactional state in lepromatous leprosy simulating Sweet's syndrome.
Das T; Ghosh S; Kundu AK; Maity A
J Assoc Physicians India; 2013 Nov; 61(11):856-8. PubMed ID: 24974510
[TBL] [Abstract][Full Text] [Related]
97. Lepromatous leprosy in erythema nodosum leprosum reaction mimicking Sweet's syndrome.
Heng YK; Chiam YT; Giam YC; Chong WS
Int J Dermatol; 2011 Sep; 50(9):1124-5. PubMed ID: 22126876
[No Abstract] [Full Text] [Related]
98. [Histoid leprosy with erythema nodosum leprosum].
Alioua Z; Sbai M; Elhaouri M; Bouzidi A; Boudi O; Ghfir M; Benomar S; Sedrati OL
Acta Leprol; 2003; 12(3):107-11. PubMed ID: 15040700
[TBL] [Abstract][Full Text] [Related]
99. Experiences with Thalidomide for Erythema Nodosum Leprosum– a retrospective study.
Darlong J; Govindharaj P; Charles DE; Menzies A; Mani S
Lepr Rev; 2016 Jun; 87(2):211-20. PubMed ID: 30212168
[TBL] [Abstract][Full Text] [Related]
100. Azathioprine in controlling type 2 reactions in leprosy: a case report.
Athreya SP
Lepr Rev; 2007 Sep; 78(3):290-2. PubMed ID: 18035780
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
